🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
AlpE is a novel drug combination under development for the treatment of TB,...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-30
Trial ID
NCT07350174
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2015-02
Trial ID
NCT02342886
The purpose of this study is to investigate the effectiveness and safety of...
Status
Not Yet Recruiting
Location
Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Start Date
2020-09
Trial ID
NCT04485156
Treatments Being Tested
Tuberculosis (TB) is caused by mycobacterial organism. It is the leading in...
Status
Recruiting
Location
National Tuberculosis Reference Laboratory
Start Date
2024-01-03
Trial ID
NCT06199921
This is a bioequivalence trial to evaluate the bioequivalence of Myrin P Fo...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-07
Trial ID
NCT01399788
Treatments Being Tested
BEAT Tuberculosis is a phase 3, open label, multi-centre, randomized contro...
Status
Completed
Location
Jose Pearson TB Hospital
Start Date
2019-08-22
Trial ID
NCT04062201
The METHOD study will examine whether adding metformin to standard antibiot...
Status
Completed
Location
Tembisa Clinical Research Centre-The Aurum Institute
Start Date
2022-03-04
Trial ID
NCT04930744
Treatments Being Tested
Tuberculous meningitis (TBM) is the most lethal form of extra pulmonary tub...
Status
Not Yet Recruiting
Location
ICMR- National Institute for Research in Tuberculosis
Start Date
2024-03
Trial ID
NCT05917340
This study is done to demonstrate bioequivalence of rifampicin component in...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-04
Trial ID
NCT01311505
Treatments Being Tested
It has been recommended that all transplant recipients undergo a tuberculin...
Status
Completed
Location
Asan Medical Center
Start Date
2010-06
Trial ID
NCT01087190
Treatments Being Tested